Blood Group Incompatibility
"Blood Group Incompatibility" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984).
| Descriptor ID |
D001787
|
| MeSH Number(s) |
G09.188.114 G12.186
|
| Concept/Terms |
Blood Group Incompatibility- Blood Group Incompatibility
- Blood Group Incompatibilities
- Group Incompatibilities, Blood
- Group Incompatibility, Blood
- Incompatibilities, Blood Group
- Incompatibility, Blood Group
|
Below are MeSH descriptors whose meaning is more general than "Blood Group Incompatibility".
Below are MeSH descriptors whose meaning is more specific than "Blood Group Incompatibility".
This graph shows the total number of publications written about "Blood Group Incompatibility" by people in this website by year, and whether "Blood Group Incompatibility" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2017 | 10 | 1 | 11 |
| 2018 | 4 | 1 | 5 |
| 2019 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Group Incompatibility" by people in Profiles.
-
Modelling suggests ABO histo-incompatibility may substantially reduce SARS-CoV-2 transmission. Epidemics. 2021 06; 35:100446.
-
Restarting LDLT During COVID-19: Early Results After Restructuring. Transplant Proc. 2021 May; 53(4):1118-1125.
-
A Case Report to Assess Passive Immunity in a COVID Positive Pregnant Patient. Am J Perinatol. 2020 10; 37(12):1280-1282.
-
[Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors]. Bull Cancer. 2019 Jun; 106(6):574-583.
-
A novel allele of the atypical chemokine receptor 1 (ACKR1) gene containing the nucleotide change c.126 T>G (p.42Glu) encodes a third Duffy blood group protein sequence antithetical to that encoding Fya and Fyb antigens. Transfusion. 2019 06; 59(6):2158-2159.
-
Donor-specific anti-HLA antibody production following pediatric ABO-incompatible heart transplantation. Pediatr Transplant. 2019 03; 23(2):e13332.
-
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation. N Engl J Med. 2018 11 08; 379(19):1846-1850.
-
Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada. Transfusion. 2018 09; 58(9):2243-2249.
-
An economic assessment of contemporary kidney transplant practice. Am J Transplant. 2018 05; 18(5):1168-1176.
-
Pediatric ABO-incompatible kidney transplantation: Evolving with the advancing apheresis technology: A single-center experience. Pediatr Transplant. 2018 05; 22(3):e13138.